Expression of SIGLEC15 correlates with tumor immune infiltration, molecular subtypes, and breast cancer progression.

PLoS One · 2024 · PMC11563486 · PMID 39541298

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

did not reach statistical significanceP = 0.052so close (0.05 < p ≤ 0.1)

Within the breast cancer cohort, a high expression of Siglec-15 in tumor cells was indicative of a more favorable overall survival (OS); however, the difference did not reach statistical significance (P = 0.052) (S5D Fig in S1 Data ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.